Pharming Group(PHAR) Stock Price Today

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

PHAR Pharming Group

Watchlist

8.740
+1.000+12.92%

Close Mar 13 16:00 ET

9.100
+0.360+4.12%

Post 16:51 ET

592.88MMarket Cap-54.63P/E (TTM)

Post-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga13:06 ET
G-III Apparel Posts Better-Than-Expected Earnings, Joins Ballard Power Systems, Dollar General And Other Big Stocks Moving Higher On Thursday
BenzingaMar 13 10:09 ET
Pharming Group Shares Are Trading Higher After the Company Reported Q4 Financial Results and Beat Its EPADS and Sales Estimates.
BenzingaMar 13 08:39 ET
Pharming Group Swings To Q4 Profit
RTTNewsMar 13 03:48 ET
Pharming Group Reports Strong 2024 Revenue Growth and Strategic Expansion
TipRanksMar 13 02:35 ET
Pharming Q4 2024 GAAP EPADS $0.05 Beats $0.01 Estimate, Sales $92.70M Beat $80.74M Estimate
BenzingaMar 13 02:19 ET

Comments

Stock_Drift

Dec 11, 2024 18:16

Pre Market Ticks 5:14am 12/11

$Sportsman's Warehouse (SPWH.US)$ $Pharming Group (PHAR.US)$ $BioXcel Therapeutics (BTAI.US)$ $Gaxos.ai (GXAI.US)$ $Rigetti Computing (RGTI.US)$ $Quantum (QMCO.US)$ $MIND Technology (MIND.US)$ $Stitch Fix (SFIX.US)$ $Frequency Electronics (FEIM.US)$ $CleanCore Solutions (ZONE.US)$ $Silexion Therapeutics (SLXN.US)$ $SEALSQ Corp (LAES.US)$
📊⚡️📊

Teddy123

Oct 10, 2024 13:28

Pharming Group announces start of Phase II clinical trial of leniolisib for primary immunodeficiencies (PIDs) with immune dysregulation

$Pharming Group (PHAR.US)$
Leiden, the Netherlands, October 10, 2024: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces the start of a Phase II, proof of concept, clinical trial evaluating leniolisib in primary immunodeficiencies (PIDs) with immune dysregulation linked to altered PI3Kẟ signaling in lymphocytes.
Pharming Group announces start of Phase II clinical trial of leniolisib for primary immunodeficiencies (PIDs) with immune dysregulation | PHARM Stock News

Mooers Radar

Jul 26, 2023 08:38

Columns US Top Gap Ups and Downs on 7/25: LOGI, UL, RTX, SPOT and More

Here are the top gap ups and downs for the stocks with a market cap above $5 billion after market closed (gaps range from large to small):
Gap Ups
1. $Logitech International (LOGI.US)$ - up 6.9%
2. $F5 Inc (FFIV.US)$ - up 5.1%
3. $Unilever (UL.US)$ - up 3.9%
4. $Packaging Corp of America (PKG.US)$ - up 3.4%
5. $Rio Tinto (RIO.US)$ - up 2.5%
6. $GE Aerospace (GE.US)$ - up 2.5%
7. $ASE Technology (ASX.US)$ - up 2.4%
8. $Datadog (DDOG.US)$ - up 2.4...

+16

Mooers Radar

Jul 12, 2023 08:41

Columns US Top Gap Ups and Downs on 7/11: HPQ, CRM, TM, PHAR and More

Here are the top gap ups and downs for the stocks with a market cap above $5 billion after market closed (gaps range from large to small):
Gap Ups
1. $Zillow-A (ZG.US)$ - up 3.4%
2. $Newell Brands (NWL.US)$ - up 3.3%
3. $Etsy Inc (ETSY.US)$ - up 3.3%
4. $Zillow-C (Z.US)$ - up 3.0%
5. $Pharming Group (PHAR.US)$ - up 2.8%
6. $HP Inc (HPQ.US)$ - up 2.4%
7. $Salesforce (CRM.US)$ - up 2.1%
8. $SK Telecom (SKM.US)$ - up 1.9%
9. $Procore Technologies (PCOR.US)$ - up 1....

+15

Mooers Radar

Jun 24, 2023 08:20

Columns US Top Gap Ups and Downs on 6/23: KMX, PHAR, HMC, SONY and More

Here are the top gap ups and downs for the stocks with a market cap above $5 billion after market closed (gaps range from large to small):
Gap Ups
1. $CarMax (KMX.US)$ - up 6.1%
2. $GlaxoSmithKline (GSK.US)$ - up 2.6%
3. $Fresenius Medical Care (FMS.US)$ - up 1.4%
Gap Downs
1. $Pharming Group (PHAR.US)$ - down 4.2%
2. $Woodside Energy (WDS.US)$ - down 3.6%
3. $Sasol (SSL.US)$ - down 3.3%
4. $ING Groep (ING.US)$ - down 2.8%
5. $Banco Santander (SAN.US)$ - down 2....

+10

PHAR Pharming Group

Trade Overview

Capital Trend

News

Comments

Trending Stocks